You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019011
Jan 2020053
Feb 2020062
Mar 20200132
Apr 2020075
May 2020071
Jun 20200196
Jul 2020032
Aug 2020043
Sep 20200170
Oct 2020052
Nov 2020092
Dec 2020076
Jan 20210115
Feb 2021023
Mar 2021022
Apr 2021052
May 2021062
Jun 2021013
Jul 2021065
Aug 2021094
Sep 20210138
Oct 20210524
Nov 20210410
Dec 20210102
Jan 20220131
Feb 2022052
Mar 2022060
Apr 2022021
May 20220119
Jun 2022065
Jul 2022051
Aug 2022071
Sep 2022065
Oct 2022061
Nov 20220218
Dec 202202411
Jan 20230213
Feb 2023091
Mar 2023085
Apr 2023031
May 2023065
Jun 2023070
Jul 2023046
Aug 20230113
Sep 20230220
Oct 202301163
Nov 202301981
Dec 20230101
Jan 20240111
Feb 20240214
Mar 202401431
Apr 202402311
May 20240132
Jun 20240201
Jul 20240263
Aug 2024093
Sep 20240155
Oct 20240173
Nov 20240295
Dec 20240221
Jan 20250336
Feb 20250231
Mar 20250182
Apr 20250204
May 202502621
Jun 20250208
Total01064291